Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Cardiology, Children's Hospital, Boston, Massachusetts 02215, USA. christopher.almond@childrens.harvard.edu <christopher.almond@childrens.harvard.edu>
Bivalirudin, a direct thrombin inhibitor, has recently emerged as a promising option for anti-coagulation during cardiopulmonary bypass in patients who cannot receive heparin. There is limited experience with the use of bivalirudin in children. We present the case of a child with heparin-induced thrombocytopenia with thrombosis (HIT Type II) who underwent successful orthotopic cardiac transplantation using bivalirudin as the primary anti-coagulant for cardiopulmonary bypass.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on